Add BrightSurf on Google Email

Early study shows cones in retinal degeneration, thought to be dormant, may retain visual function

Researchers discovered that 'dormant' cone photoreceptors in retinal degeneration continue to produce responses to light and drive retinal activity for vision. The study found that while cones have reduced sensitivity, ganglion cells retain their ability to respond to visual stimuli with similar spatial and temporal sensitivity.

Discovery suggests new way to prevent common causes of vision loss

UVA scientists have discovered a new contributor to abnormal blood vessel growth in the eye, which could lead to new treatments for macular degeneration and other vision loss conditions. The discovery identifies a key protein that determines VEGF levels, blocking it has reduced VEGF levels significantly without unwanted side effects.

SourceUniversity of Virginia Health System·JournalSignal Transduction and Targeted Therapy·DateFeb 24, 2023

CityU neuroscientists identify a small molecule that restores visual function after optic nerve injury

A research team led by Dr. Eddie Ma Chi-him identified a therapeutic small molecule M1 that increases mitochondrial dynamics and sustains long-distance axon regeneration, restoring visual functions in mice. Regenerated axons elicited neural activities and survived for four weeks after optic nerve injury.

SourceCity University of Hong Kong·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 20, 2023

Aging | Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization

In a mouse model of laser-induced CNV, RORα expression was highly increased in the choroidal/RPE complex post-laser, while loss or inhibition of RORα worsened CNV with increased lesion size and vascular leakage. RORα negatively regulates pathological CNV development by modulating angiogenic response and inflammatory environment.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJan 18, 2023

Mount Sinai researchers first to identify that two separate eye diseases may contribute to common blinding eye condition

Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalEye·TypeObservational study·DateJan 9, 2023

Blinding eye disease strongly associated with serious forms of cardiovascular disease

A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalBMJ Open Ophthalmology·TypeImaging analysis·DateNov 17, 2022

How squid and octopus get their big brains

Researchers discovered that cephalopods develop their large nervous systems using similar mechanisms as vertebrates, with a focus on the retina. This study provides insight into the developmental process of these intelligent creatures and could lead to new discoveries about human brain development.

SourceHarvard University·JournalCurrent Biology·TypeExperimental study·DateNov 9, 2022

Powerful enzyme that tamps down inflammation holds promise for protecting the eyes in diabetes, premature birth

Researchers found that increasing arginase 1 availability helps alleviate unhealthy responses and interrupt destructive inflammation in diabetic retinopathy and retinopathy of prematurity. This is achieved by reducing L-arginine levels, which in turn reduces inducible nitric oxide synthase activity.

SourceMedical College of Georgia at Augusta University·JournalCell Death and Disease·DateOct 12, 2022

Turning the spotlight on cells in tissues so RNA can tell their story

Researchers have developed a new DNA nanotechnology-driven method called Light-Seq that enables the analysis of gene expression patterns in hard-to-access cells within intact tissues. This approach overcomes limitations of existing spatial transcriptomics methods, allowing for deeper understanding of disease mechanisms and biology.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Methods·TypeExperimental study·DateOct 10, 2022

New diagnostic option for rare eye disease

Researchers at the University of Bonn have tested color-coded fundus autofluorescence as a supportive novel diagnostic method for posterior uveitis. The results indicate that this ratio can be very characteristic and helpful in differentiating various posterior uveitis subtypes.

SourceUniversity of Bonn·JournalScientific Reports·TypeExperimental study·DateAug 29, 2022

Progress toward a stem cell–based therapy for blindness

A new study successfully introduces healthy photoreceptor cells derived from stem cells into the retinas of dogs, marking significant progress toward a cell-based therapy for blindness. The treatment enables cells to survive and form connections with existing retinal cells, paving the way for a regenerative medicine approach.

SourceUniversity of Pennsylvania·JournalStem Cell Reports·TypeExperimental study·DateJul 28, 2022

Eyes a haven for Ebola and other viruses

Researchers found that retinal cells are more susceptible to Ebola virus infection than iris cells, which could lead to uveitis diagnosis and treatment. This discovery highlights the importance of monitoring retinal cells during acute viral infections to identify patients at high risk.

SourceFlinders University·JournalFrontiers in Virology·TypeExperimental study·DateJun 19, 2022

When it comes to ADHD and ASD, the eyes could reveal all

New research from University of South Australia and Flinders University uses retina recordings to identify distinct signals for Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), providing a potential biomarker for each condition. Children with ADHD showed higher overall energy, while those with ASD sho...

SourceUniversity of South Australia·JournalFrontiers in Neuroscience·TypeExperimental study·DateJun 17, 2022

Bringing daylight back into view: Scientists transplant human photoreceptors to successfully recover daylight perception in mice

Researchers at TU Dresden have developed a method to produce high numbers of human photoreceptor cells that can incorporate into partially degenerated mouse retinas and restore daylight perception. The incorporated photoreceptors developed characteristics of normal photoreceptors and could detect daylight in mice with damaged eyesight.

Drug treatment for cataracts moves a step closer

A team of scientists led by Professor Barbara Pierscionek has made significant progress in developing an anti-cataract drug. Lab trials showed improvement in refractive index profiles and lens opacity in 61% and 46% of cases, respectively.

SourceAnglia Ruskin University·JournalInvestigative Ophthalmology & Visual Science·TypeRandomized controlled/clinical trial·DateMay 16, 2022

Retinal cell map could advance precise therapies for blinding diseases

A new study maps the distinct differences among cells in the retina's retinal pigment epithelium (RPE), which nourishes and supports photoreceptors. The research identifies five subpopulations with varying levels of disease sensitivity, opening doors to more precise cell and gene therapies for specific degenerative eye diseases.

SourceNIH/National Eye Institute·JournalProceedings of the National Academy of Sciences·DateMay 6, 2022

Correcting night blindness in dogs

Researchers have developed a gene therapy that restores night vision in dogs with congenital stationary night blindness (CSNB), a condition affecting the ON bipolar cells. The treatment enables dogs to navigate mazes in dim light and has a lasting therapeutic effect, paving the way for potential human treatments.

SourceUniversity of Pennsylvania·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 22, 2022